- Home
- SCHL vs PVLA Comparison
SCHL vs PVLA Comparison
Compare SCHL & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCHL
- PVLA
- Stock Information
- Founded
- SCHL 1920
- PVLA 2015
- Country
- SCHL United States
- PVLA United States
- Employees
- SCHL N/A
- PVLA N/A
- Industry
- SCHL Books
- PVLA Biotechnology: Pharmaceutical Preparations
- Sector
- SCHL Consumer Discretionary
- PVLA Health Care
- Exchange
- SCHL Nasdaq
- PVLA Nasdaq
- Market Cap
- SCHL 644.1M
- PVLA 604.2M
- IPO Year
- SCHL 1987
- PVLA N/A
- Fundamental
- Price
- SCHL $27.54
- PVLA $59.04
- Analyst Decision
- SCHL Strong Buy
- PVLA Strong Buy
- Analyst Count
- SCHL 1
- PVLA 12
- Target Price
- SCHL $37.00
- PVLA $59.00
- AVG Volume (30 Days)
- SCHL 270.3K
- PVLA 116.2K
- Earning Date
- SCHL 09-18-2025
- PVLA 11-15-2025
- Dividend Yield
- SCHL 2.90%
- PVLA N/A
- EPS Growth
- SCHL N/A
- PVLA N/A
- EPS
- SCHL N/A
- PVLA N/A
- Revenue
- SCHL $1,625,500,000.00
- PVLA N/A
- Revenue This Year
- SCHL $4.15
- PVLA N/A
- Revenue Next Year
- SCHL $3.96
- PVLA N/A
- P/E Ratio
- SCHL N/A
- PVLA N/A
- Revenue Growth
- SCHL 2.25
- PVLA N/A
- 52 Week Low
- SCHL $15.77
- PVLA $11.17
- 52 Week High
- SCHL $34.18
- PVLA $61.48
- Technical
- Relative Strength Index (RSI)
- SCHL 63.46
- PVLA 65.61
- Support Level
- SCHL $26.69
- PVLA $53.30
- Resistance Level
- SCHL $28.20
- PVLA $61.48
- Average True Range (ATR)
- SCHL 0.99
- PVLA 3.92
- MACD
- SCHL 0.06
- PVLA -0.49
- Stochastic Oscillator
- SCHL 82.72
- PVLA 79.08
About SCHL Scholastic Corporation
Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.
About PVLA Palvella Therapeutics Inc. Common Stock
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.